Israel VC Funds

Korify Capital, based in Basel, Switzerland, focuses on early and growth-stage investments in the biotech sector, particularly targeting longevity and mental health. Launched by Robin and Peter Lauber’s family office, Infinitas Capital, Korify Capital aims to drive forward breakthrough technologies that can extend healthy lifespan and address mental health issues. Notable investments include Alto Neuroscience, which uses AI-derived brain biomarkers to develop psychiatric treatments, and Cambrian Biopharma, which is pioneering therapeutics to lengthen healthspan by targeting the biological drivers of aging. Another significant investment is Gameto, which focuses on improving assisted fertility and tackling ovarian aging through cellular reprogramming. Korify Capital also invests in companies like Refoxy, which develops medicines to treat age-related diseases by modulating stress response pathways, and Rejuveron, a biotech firm aiming to transform aging-related scientific discoveries into practical treatments. These investments demonstrate Korify’s commitment to supporting innovative approaches in the biotech field, aiming to enhance longevity and overall health. The firm’s strategy involves leveraging its extensive venture capital network and deep expertise in biotech to support these transformative companies, helping them achieve significant milestones and growth.

Krypton Venture Capital is an Israeli seed-stage venture capital firm founded in 2014 by Moshe Sarfaty, based in Bnei Brak. Now operating as Krypton VC 4.0, the fund invests in tech and internet ventures at the initial revenue stage across a wide range of verticals including B2B SaaS, fintech, mobile, insurtech, fashiontech, traveltech, foodtech, marketplaces, e-commerce, gaming, video, social, adtech, and blockchain. Sarfaty holds dual degrees in Economics and International Studies from Yale University and brings years of experience in investment banking, trading, business valuation, and equity funds. Krypton leads rounds and invests $250,000 to $2.5 million per deal, with a sweet spot of $1.5 million. The fund's differentiated approach centers on the proprietary Krypton Investment Mechanism — a hands-on method focused on rapidly launching products to market without lengthy due diligence processes, instead leveraging intimate working experience and marketing expertise. The team includes Eldar, formerly a senior business analyst at Giza Singer Even, Israel's largest financial advisory firm. The fund is now on its fourth iteration, suggesting a consistent track record of deploying and returning capital across multiple cycles. Krypton's investment philosophy frames the startup world as a competitive arena where timing and execution matter more than prolonged analysis. The firm aims to give founders the tools for a decisive market entry rather than an extended development cycle. While portfolio names are not publicly tracked, the fund's longevity — spanning four fund cycles since 2014 — reflects sustained LP confidence in the approach.

L&S Venture Capital is a Seoul, South Korea-based venture capital firm founded in 2006, managing approximately 501.8 billion won, equivalent to roughly $400 million USD. The firm has a team of 15 including 6 partners, investing from incubation and seed stages through early and expansion rounds, with typical check sizes of $1 million to $5 million at Series A. L&S leads rounds and has one of the most impressive IPO track records among Korean venture firms, with 26 portfolio IPOs and 3 acquisitions across 90 total investments. The firm's investment focus spans semiconductors, materials, components and equipment, artificial intelligence, IoT, cloud computing, big data, mobile and network infrastructure, and e-healthcare. Notable IPO exits include INNOSPACE (space launch technology, KRX listing in July 2024 at a $293 million market capitalization), E8IGHT (KRX, $142 million market capitalization), SillaJen (oncolytic immunotherapy biopharmaceutical), and PharmAbcine (antibody therapeutics). The most notable acquisition was Panax Etec, sold to Dongwha Enterprise in August 2019 for $97.1 million. The most recent investment was AIRS at Series A in March 2025, with recent activity also including Align AI and Ettifos. L&S also invests in Israel alongside its primary focus on the Seoul, Gyeonggi, and Chungnam regions of Korea. L&S provides financial, business, and strategic support to portfolio companies across smart IT, green energy, fusion technology, and media content sectors. The firm's sustained 90-investment track record and 26-IPO exit history reflect a deep integration with the Korean capital markets ecosystem and a proven ability to guide technology companies through public listing processes.

Landa Ventures is the venture capital investment arm of the Landa Group, founded in 2003 in Rehovot, Israel by Benny Landa, one of Israel's most prominent technology entrepreneurs. Landa previously founded Indigo Digital Printing, a company that revolutionized the commercial printing industry and was later sold to HP. Mimi Sela serves as CEO and Managing Director of the fund. The team of three partners includes a CFO responsible for financial management and board roles across portfolio companies. The firm invests only in companies where it can actively add value. Landa Ventures leads rounds and focuses on seed and startup-stage investments with check sizes in the $500,000 to $3 million range. The fund has made approximately 34 investments across sectors including space technology, satellite communications, big data, healthtech, energy, imaging, and personal care. Named portfolio companies include Evigence Sensors (freshness monitoring technology for food supply chains, Series B in January 2023), NovelSat (satellite modems with cutting-edge signal efficiency), Twine Solutions (digital continuous thread dyeing technology, exited September 2025), and Kampalook (hair color and care products). The fund has invested across companies from early deep-tech R&D through commercial growth stages, reflecting Benny Landa's own history of innovation at the frontier of imaging and materials science. Landa Ventures approaches investing with the conviction that identifying and backing disruptive solutions in large markets, combined with active operational involvement, can generate outsized outcomes. The firm's connection to Benny Landa's scientific and entrepreneurial legacy gives it credibility with deep-tech founders, particularly in sectors adjacent to materials, imaging, and physical-world technology platforms.

Lauxera Capital Partners is a healthcare-focused investment firm, specializing in growth-stage companies that are scientifically de-risked and have clear commercial pathways. Founded in 2020, the firm operates from Paris and San Francisco, with a focus on innovative healthcare sectors like medical devices, digital health, diagnostics, life sciences tools, and healthcare IT. They invest when startups have a proven revenue model and are ready to scale, contributing both capital and strategic expertise. Lauxera manages over €260 million through its Lauxera Growth I fund and typically invests between €300,000 and €3 million per startup. The firm is known for its hands-on approach, leveraging the operational experience of its team to support management in overcoming growth challenges and optimizing market adoption. Notable investments include Natural Cycles and Caresyntax, highlighting their commitment to cutting-edge health technologies​. Lauxera’s global perspective and strong European roots, combined with its healthcare expertise, make it a valuable partner for startups aiming to scale in large healthcare markets​.

Lead Edge Capital is a growth equity firm managing over $5 billion in assets, with a focus on software, internet, and tech-enabled businesses. The firm invests in both private and public companies, typically deploying between $25 million and $300 million. Notable portfolio companies include Alibaba, Toast, Grafana, and Wise, showcasing a strong track record across diverse sectors. The firm’s strategy revolves around leveraging its extensive network of 700+ executives and industry leaders to drive growth through strategic partnerships and customer acquisition. Lead Edge is highly flexible, offering both minority and buyout investments to companies with $10 million+ in revenue and 25%+ year-on-year growth. Geographically, Lead Edge operates from New York and Santa Barbara but invests globally. They typically engage in late-stage funding rounds, often as co-investors, and aim to bring more than just capital to the table. Founders benefit from Lead Edge’s vast network, which is a key part of their value proposition. The team is led by professionals like Evan Skorpen (Partner, Public Markets), with deep expertise in tech and finance. Startups looking to engage should focus on demonstrating scalable growth and recurring revenue models to catch their attention.

Leaps by Bayer, founded in 2015, is Bayer AG's strategic impact investment unit focusing on transformative biotechnologies in health and agriculture. Since its inception, Leaps by Bayer has invested over $1.9 billion in more than 60 ventures, targeting significant challenges through ten key "leaps" designed to address pressing global issues. Key investments include Recursion Pharmaceuticals, which focuses on drug discovery using AI, and BlueRock Therapeutics, a company specializing in cell therapy. These investments align with their strategic goals such as curing genetic diseases, developing sustainable organ and tissue replacements, and reducing the environmental impact of agriculture. Leaps by Bayer's portfolio companies operate autonomously, but benefit from Bayer’s active incubation model, which provides resources and strategic guidance. This approach helps them focus on long-term, high-impact results rather than short-term gains. Leaps by Bayer also collaborates globally with partners in industry, academia, and civil society to drive these innovations forward.

Left Lane Capital is a prominent venture capital firm headquartered in Brooklyn, New York, with an additional office in London. Founded in 2019, the firm specializes in investing in high-growth internet and consumer technology companies. Their mission is to support companies that are driving the digitization of the real economy by providing them with actionable insights and operational support to achieve hyper-scale growth. The firm's investment portfolio includes notable companies such as GoStudent, Jackpocket, and Bilt Rewards. GoStudent is a Vienna-based digital marketplace for online tutoring, Jackpocket is a mobile lottery platform, and Bilt Rewards is a consumer finance and rewards company focused on property renters. Other significant investments include Talkiatry, a behavioral healthcare company, and Blinkist, a service that provides key insights from non-fiction books in audio and text formats. Left Lane Capital typically invests between $5 million and $75 million, often leading or co-leading rounds. They focus on sectors such as fintech, healthtech, e-commerce enablement, and SaaS, supporting both B2B and B2C business models. The firm prides itself on a data-driven approach and a deep understanding of their portfolio companies' markets and customers. The team is led by founder and CEO Harley Miller, along with managing partners Avneet Pujji, Daniel Ahrens, and Jason Fiedler. They bring extensive experience and a commitment to working closely with founders to navigate the challenges of scaling businesses.

The LEO Foundation is one of Denmark's largest commercial foundations, primarily focused on supporting research in dermatology. Established in 1984, it is the controlling shareholder of LEO Pharma, a leading company in medical dermatology with a strong R&D pipeline. The foundation’s main objective is to ensure the long-term development and success of LEO Pharma while also providing philanthropic grants to advance skin disease research globally. The foundation holds financial assets worth approximately EUR 2.2 billion. Their investment strategy emphasizes generating attractive returns to support LEO Pharma’s strategic growth and funding their philanthropic activities. The portfolio is diversified across asset classes, including listed shares, bonds, and alternative investments like private equity and real estate. Investments are managed by a small team within their subsidiary, LEO Holding A/S, and through external professional asset managers. In 2022, the foundation awarded DKK 125 million across 36 grants to support diverse dermatological research projects. They also faced challenges from a tough macroeconomic environment, resulting in a negative return on investments. However, the foundation remains committed to its long-term goals, including enhancing its grant-giving capacity and supporting LEO Pharma’s profitability and growth strategies.

Levitate Capital is a venture capital firm dedicated to investing in the future of air mobility, drones, and space technology. Based in the San Francisco Bay Area, Levitate Capital focuses on early-stage ventures that are pioneering the next generation of transportation and logistics through advanced air and space technologies. The firm’s investment strategy covers a wide range of innovative companies, from those developing electric and autonomous flight systems to those building the infrastructure and business models necessary to support these emerging industries. Levitate Capital is driven by the belief that we are on the brink of a revolution in how airspace is utilized, not just for transportation but also for security, data capture, and global development. Their portfolio includes groundbreaking companies like Joby Aviation, the first publicly listed eVTOL (electric vertical take-off and landing) company, and Volocopter, a leading electric air taxi service provider. Additionally, they invest in enabling technologies such as Skydio, a leader in autonomous drone technology, and Spire Global, which provides satellite data and analytics. The firm’s approach is not only to back these high-tech ventures financially but also to support them in realizing their full potential within the rapidly evolving air mobility landscape. Levitate Capital’s focus on sustainable and innovative solutions positions them at the forefront of the transformation in how humanity interacts with the skies.

LG Technology Ventures, founded in 2018 and based in Santa Clara, California, is the corporate venture capital arm of LG Group. The firm focuses on investing in early-stage companies across various sectors, including artificial intelligence, information technology, automotive, life sciences, and energy. With over $400 million in managed assets, LG Technology Ventures aims to drive innovation and growth by partnering with promising startups. Their portfolio includes notable investments in companies like H2O.ai, which offers an open-source machine learning platform; The Sandbox, a virtual metaverse game; and Moloco, which provides AI-enabled mobile DSP software. They have also invested in Element Energy, a battery technology company, and Eatron Technologies, specializing in AI for automotive and electric vehicles​​. The team at LG Technology Ventures consists of experienced investors, technologists, and industry experts, led by Dong-Su Kim, Ph.D., who serves as the CEO. The firm is known for its strategic approach, often leading investment rounds and providing substantial support to its portfolio companies to help them scale and succeed globally.​

Libertad Ventures is the Mossad's Technological Innovation Fund, established in June 2017 as the strategic investment arm of the Israel Security and Intelligence Service. Libertad invests in breakthrough technologies using a unique equity-free model: the fund provides grants of up to NIS 2 million (approximately $580,000) per startup with no equity stake, no share ownership, no IP restrictions, and no royalty repayment. In return, the Mossad receives a non-commercial, non-exclusive license to use the developed intellectual property. The fund operates with an annual budget of approximately NIS 10 million ($2.9 million), typically funding 5 startups per year, and has completed over 30 deals since 2017. Libertad's investment scope covers more than 16 technology domains: fintech, robotics, data science, drones, personality profiling, big data, energy harvesting, natural language processing, voice analysis, AI, 3D printing and scanning, blockchain, machine learning, synthetic biology, smart city technology, and online privacy. The fund leads its supported projects and allocates dedicated teams to each portfolio company, maintaining collaborative working relationships throughout the R&D process. Portfolio company names are not publicly disclosed due to the classified nature of the parent organization. The fund accepts hundreds of applications annually and has expanded its scope over time to accommodate emerging fields. Libertad is analogous to the CIA's In-Q-Tel in its role as an intelligence agency's technology investment arm, but operates with a fundamentally different economic model. The equity-free grant structure removes the commercialization friction that typically constrains deep-tech startups, allowing founders to retain full ownership while developing technologies that address national security and intelligence requirements.

Liberty Hall Capital Partners is a private equity firm based in Charleston, South Carolina, that focuses exclusively on investments in the global aerospace and defense industry. Since its inception in 2005, Liberty Hall has invested over $2.5 billion in equity capital across 28 acquisitions, including both platform and add-on acquisitions. Notable current investments include Accurus Aerospace Corporation, a supplier of engineered structural parts and assemblies; Comply365, a provider of compliance and data intelligence technologies; and Dunlop Aircraft Tyres, a designer and supplier of aircraft tires​​. The firm’s investments span across significant commercial, business jet, military aircraft platforms, and select space platforms. Liberty Hall's investment strategy is to leverage its extensive industry expertise and network to support portfolio companies in achieving significant growth and operational improvements. The firm is recognized for its hands-on approach and deep involvement in the strategic development of its portfolio companies.

Lightbank, founded in 2010 by Brad Keywell and Eric Lefkofsky, is a venture capital firm based in Chicago, Illinois. The firm focuses on early-stage investments, typically in pre-seed, seed, and Series A rounds, with initial check sizes ranging from $250,000 to $5 million. Lightbank has built a diverse portfolio across various sectors, including consumer, enterprise, healthcare, fintech, and climate tech. Among Lightbank's most notable investments are Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare; Sprout Social, a social media management and marketing platform that went public in 2019; Udemy, an online learning and teaching marketplace with over 155,000 courses; Fiverr, an online marketplace for freelance services, which also went public; and Ovia Health, a women's health and family health company acquired by Labcorp. Lightbank has made a total of 219 investments and has had 91 exits, demonstrating a strong track record of successful investments and strategic exits. The firm's latest investments include companies like Aropha and Ohana Subleasing Co., continuing their commitment to innovative and high-potential startups.

Lightspeed Venture Partners is a prominent venture capital firm based in Menlo Park, California. Established in 2000, Lightspeed has a rich history of investing in a wide array of sectors including enterprise, consumer, fintech, and healthcare. The firm is known for its deep commitment to supporting companies from seed stage through growth stage. Lightspeed's portfolio includes several high-profile companies. They were early investors in Snapchat, Nutanix, MuleSoft, and AppDynamics, all of which have become significant players in their respective industries. Other notable investments include Affirm, Nest, and Ripple, demonstrating Lightspeed's diverse investment strategy and success across various markets​​. In 2020, Lightspeed raised $4.2 billion across three funds to continue supporting early-stage ventures and growth-stage companies. Their investment philosophy focuses on building strong, enduring companies with a hands-on approach, helping founders navigate the complexities of scaling their businesses​​. With a global presence, Lightspeed operates in several countries including the United States, Israel, India, and China. Their international portfolio reflects their ability to identify and nurture innovative companies worldwide.

Lightstone Ventures, founded in 2012, is a venture capital firm that focuses on early-stage investments in the life sciences sector. The firm is based in Menlo Park, California, with additional offices in Boston and Dublin. Lightstone Ventures has a strong track record of investing in biopharmaceutical and medical device companies. Notable investments by Lightstone Ventures include companies such as Reprieve Cardiovascular, which focuses on innovative treatments for heart failure, and Carrick Therapeutics, a biopharmaceutical company developing treatments for cancer. Another significant investment is in Catamaran Bio, which is advancing cell therapies for cancer. The firm recently closed its third fund at $375 million, which will be used to support early-stage companies developing high-impact therapeutics and technologies. Lightstone Ventures' investment strategy emphasizes translating novel scientific breakthroughs into clinically and commercially meaningful therapies. This approach has resulted in successful exits, such as Ra Pharmaceuticals and Disarm Therapeutics, highlighting their ability to nurture companies from inception to market success.

Link Ventures is a prominent Nordic venture capital firm with a strategic focus on accelerating the energy transition and building scalable technology solutions. Specializing in early-stage investments from pre-seed to Series A, Link Ventures prioritizes sectors such as clean energy, software, mobility, and tech that drive sustainable development. Notable investments by Link Ventures include SolarDuck, an innovative player in marine technology and renewable energy, and Glint Solar, specializing in AI-driven solar energy solutions. They actively invest in startups like Vignita, focusing on B2B corporate training, and Rightcharge, enhancing automotive charging solutions. Geographically, Link Ventures has a strong presence in Nordic and European markets, aiming to support over 100 early-stage companies across Europe. Their investment strategy involves not only financial backing but also active involvement in portfolio companies through strategic support, networking, and board representation. They typically invest between €100,000 to €5M, often leading investment rounds. The team at Link Ventures is led by seasoned professionals including Elisabeth Øvstebø, Founding Partner and Investment Director, and Christian Rangen, Chairman of the Board. They are based in Norway and are recognized for their hands-on approach and commitment to creating high-impact, sustainable businesses. Startups looking to engage with Link Ventures are encouraged to approach with a clear focus on innovation and sustainability, aligning with the firm's mission to foster the next generation of technology that addresses global energy challenges​.

Linse Capital is a growth equity firm that focuses on investing in transformative industrial technology companies across sectors such as transportation, energy, logistics, and real estate. Founded in 2017 and based in Menlo Park, California, the firm seeks to back companies that have the potential to make a profound impact on some of the world's largest industries. Linse Capital is particularly interested in companies driving advancements in electric vehicles, autonomous vehicles, robotics, renewable energy, and space. The firm’s strategy is to invest heavily in a small number of high-conviction bets, typically making capital commitments between $100 million and $400 million per company. Linse Capital's portfolio includes notable companies like ChargePoint (a leader in electric vehicle charging infrastructure), Skydio (an autonomous drone manufacturer), and Redaptive (an energy-as-a-service provider). They focus on deep involvement with their portfolio companies, helping them scale by leveraging Linse’s extensive network and resources. Linse Capital has raised over $1.1 billion in committed capital, backed by a mix of family offices, institutional investors, and strategic partners from industries like transportation and energy​.

LionBird, founded in 2012 and based in Tel Aviv and Chicago, focuses on early-stage investments in digital health companies. The firm targets startups that are leveraging technology to innovate and improve healthcare delivery and outcomes. Their diverse portfolio includes companies such as Ovia Health, a leader in family health solutions; Marqeta, a modern card issuing platform; and Bizzabo, an event management software company. LionBird has achieved notable exits including Ovia Health and Marqeta, which underline their strategic investment approach and successful track record. LionBird recently closed its third fund at $85 million, indicating strong support from institutional investors like the Healthcare of Ontario Pension Plan (HOOPP). This fund is set to invest in 15 to 20 early-stage companies within the digital health sector, reinforcing their commitment to transforming healthcare through technology. The firm is co-founded by Edward Michael JD, Chaim Friedman, and Jonathan Friedman, who bring extensive experience and a strong network to support their portfolio companies. LionBird aims to provide more than just capital, offering strategic guidance and resources to help startups navigate the complexities of the healthcare industry and achieve market fit.

LongeVC is a venture capital firm specializing in early-stage investments in biotechnology, with a strong focus on longevity and age-related innovations. Based in Lugano, Switzerland, and Latvia, the firm targets breakthrough startups in sectors like biotech, life sciences, and therapeutics that aim to extend human health and longevity. LongeVC typically invests between €0.5 million and €2.3 million in companies across Europe, the U.S., and Israel. The firm is backed by a deep scientific advisory board and meticulously prioritizes scientific due diligence. Their portfolio includes leading biotech startups such as Insilico Medicine, known for AI-driven drug discovery, and Longenesis, which provides tools for collaborative biotech research. LongeVC's mission is to bring life-changing health technologies to market, addressing global challenges like aging and healthcare. Led by partners like Ilya Suharenko and Garri Zmudze, LongeVC offers not only capital but also strategic business development support, helping founders build scalable businesses that can make a global impact.

Lonza is a global leader in the life sciences industry, providing contract development and manufacturing services (CDMO) for the pharmaceutical, biotech, and nutrition sectors. With headquarters in Basel, Switzerland, Lonza operates over 50 sites worldwide, offering end-to-end solutions across biologics, small molecules, cell and gene therapies, and more. In addition to its CDMO services, Lonza is deeply involved in venture capital through strategic partnerships and investments. The company collaborates with venture capital firms like ALSA Ventures and Bioqube Ventures to support emerging biotech startups, focusing on developing innovative therapies. Lonza's role in these partnerships often includes early-stage de-risking, development, and manufacturing services, helping startups navigate the complexities of bringing new treatments to market. Lonza has also launched a venture capital fund with Prolog Ventures to invest in North American health and wellness startups. This fund is part of Lonza's broader strategy to foster innovation in the health sector by supporting companies that align with its mission to improve patient outcomes and address unmet medical needs​.

Lorimer Ventures is a venture capital firm that specializes in investing in early-stage B2B SaaS companies. Their key focus areas include fintech, e-commerce tooling, developer tools, intelligent infrastructure, and future of work applications. They pride themselves on being highly supportive and responsive, often engaging deeply with their portfolio companies to provide strategic guidance, introductions to customers, investors, and talent, and valuable insights from their extensive network of experienced operators and executives. The team at Lorimer Ventures includes notable figures like Stephan Cizmar, a serial entrepreneur with a background in scaling B2B software companies, and Nick Wijnberg, an investor with extensive experience in finance and agribusiness. They are complemented by operating partners like Pete Schork and Zach Magdovitz, who bring expertise in sustainable energy, mobility, and product management​. Lorimer Ventures has built a diverse portfolio of innovative companies, including TakeShape, Northbeam, Polar Signals, and Capchase, among others. Their approach is to roll up their sleeves and work closely with founders to drive their businesses forward.

Loyal VC is a global venture fund established in 2018 that operates a startup index fund with over 350 investments across more than 60 countries. The firm is known for its unique gate-stage investment process, which reduces systemic bias and aims to unlock greater returns. This process involves multiple rounds of diligence and quarterly redemptions, offering flexibility to high-net-worth individuals and institutions. Loyal VC collaborates closely with INSEAD, Founder Institute, and a network of over 1,000 advisors. This extensive network supports a diverse portfolio of founders, with more than 30% of the portfolio companies led by women CEOs and nearly 30% based in emerging markets. The firm places a strong emphasis on social impact, with 80% of its investments aligned with one or more of the UN Sustainable Development Goals (SDGs). Notable investments by Loyal VC include Sama, a company that brings transparency and verifiability to cross-border blue-collar recruitment, and TechStyle, a digital marketplace for sustainable material sourcing in the fashion industry. The firm also supports companies like CurieMD, a telemedicine platform for menopause care, and Milestone, a financial literacy app aimed at helping parents raise financially responsible children. Loyal VC’s investment focus spans various sectors, including cleantech, fintech, healthcare, and more, reflecting their commitment to backing innovative solutions across the globe. For more information, you can visit their official website.

LVMH Luxury Ventures is the investment arm of LVMH, designed to support early-stage and high-growth luxury startups. This venture capital division was established to invest in emerging brands that align with LVMH’s core values of innovation, craftsmanship, and exclusivity. Targeting sectors such as fashion, beauty, and retail technology, LVMH Luxury Ventures provides both capital and strategic support, enabling young luxury brands to scale internationally. The venture arm seeks brands with strong creative potential and unique market positioning. By offering access to LVMH’s vast global network and industry expertise, the venture fund supports companies not just financially but also through product development, distribution, and marketing strategies. This integrated approach ensures that the startups benefit from LVMH’s experience and resources, facilitating their growth in the highly competitive luxury market. Some of LVMH Luxury Ventures’ notable investments include stakes in luxury fashion houses and innovative brands like Stella McCartney, MadHappy, and Gabriela Hearst. These brands, known for their creativity and sustainability focus, represent LVMH’s commitment to staying ahead of emerging trends in the luxury space while fostering entrepreneurship and innovation. By integrating these new brands into its ecosystem, LVMH expands its influence and ensures sustainable growth for both the conglomerate and its portfolio companies. This investment strategy allows LVMH to remain at the forefront of luxury innovation while supporting the next generation of high-end brands poised to lead the market in the future.

Lyra Ventures is an early-stage venture capital firm founded in 2017 and based in Singapore, investing globally in companies that use innovative technology to reinvent the business of fashion and retail. The firm is backed by ZOZO Co., Ltd., Japan's largest fashion e-commerce platform, and TSI Holdings, one of Japan's largest fashion conglomerates. Lyra's investment focus spans the entire fashion value chain — materials innovation, new retail models, circular economy processes, brand concepts, and SaaS tools — backing founders with demonstrated product-market fit who are ready to scale. The team of 16 includes two partners, one venture partner, and one principal, with offices in Singapore, Japan, and five or more additional locations. Lyra leads rounds and has invested in 21 companies across two funds. Named portfolio companies include Balance, which closed a $56 million Series B co-led by Lyra and Salesforce Ventures; Entrupy, an AI-based luxury goods authentication platform; LePrix, a B2B wholesale marketplace for secondhand luxury goods; SuperCircle, a textile recycling company; Material Exchange, a materials sourcing platform; Threedium, a 3D product visualization tool; and Tolstoy, an interactive video commerce platform. The portfolio has seen two acquisition exits: Syte, a visual AI platform for retail, and 1Mentor. The most recent investment was illumex in June 2024. Lyra's backing by ZOZO and TSI Holdings gives portfolio companies more than capital — it provides direct access to two of Japan's largest fashion ecosystems, creating commercial pathways for companies seeking to enter the Japanese market or leverage Japanese manufacturing and logistics relationships. Entrepreneurs in Lyra's portfolio gain deep fashion industry domain knowledge and an extensive network of global fashion players through the firm's team and advisors.

M Ventures is the strategic corporate venture capital fund of Merck KGaA (Darmstadt, Germany), created in 2009 and headquartered in Amsterdam, Netherlands, with additional offices in Germany, Israel, and the United States. The fund invests with dual strategic and financial objectives across biotechnology and technology, covering four areas: healthcare drug development, life science tools, electronics, and frontier technology and sustainability. In 2021, Merck expanded M Ventures with an additional €600 million commitment — the third increase since the fund's creation — enabling larger and more frequent investments. The team of seven is led by CEO Howard H. Thaw. M Ventures leads rounds and has made 133 investments with 20 portfolio exits, the most recent being Calypso Biotech in January 2024. A recent landmark deal was the co-led $75.5 million oversubscribed Series A for Actithera in July 2025, a radiopharmaceutical biotech developing next-generation radioligand therapies. The biotech portfolio focuses on emerging biotechnologies leading to differentiated drugs, R&D tools, and platforms with significant potential to improve patient outcomes. The technology portfolio invests in companies developing new solutions for information access, storage, processing, and display, as well as sustainability challenges. Geographic scope is global, with concentrations in Europe, Israel, and the United States. M Ventures takes an active role in portfolio companies and facilitates seed-stage company creation, early-stage syndicated investments, and the creation and funding of Merck spin-offs. Portfolio companies benefit from Merck's deep scientific networks, laboratory infrastructure, and relationships with global pharmaceutical and specialty chemical companies across Merck's three business sectors: life science, healthcare, and electronics.

Maccabee Ventures, established in 2019 and based in New York City, is an early-stage venture capital firm focused on investing in tech startups. Founded by Yeshiva University alumni, the firm leverages the university's extensive global alumni network to support its portfolio companies with industry expertise and strategic connections. The firm targets investments in various sectors, including SilverTech™, digital health, enterprise/B2B, fintech, cybersecurity, and converging technologies like AI and machine learning. Maccabee Ventures typically invests in pre-seed and seed-stage companies, with initial investments ranging from $50,000 to $150,000, and can provide follow-on funding up to $300,000. Notable investments in Maccabee Ventures' portfolio include companies such as Fundbox, a fintech platform for business loans; Hootsuite, a social media management platform; and Eleos Health, which leverages AI for digital health solutions. The firm also has investments in innovative companies like Clocr (digital inheritance and asset protection), Shabodi (5G technology), and Tembo Health (telemedicine)​. Maccabee Ventures prides itself on building meaningful relationships with founders and providing strategic support to help companies grow and scale. This includes leveraging Yeshiva University's resources and a network of over 70,000 alumni for expertise in various fields.

Macquarie Capital is the advisory, capital markets, and principal investment arm of the Macquarie Group, a global financial institution with a 30-year track record of investing in technology-driven businesses. Specializing in early-stage and growth-stage investments, Macquarie Capital focuses on sectors like cybersecurity, fintech, AI, regulatory technology, and food services, helping startups scale globally. The firm’s flexible investment model allows them to lead funding rounds and provide strategic support throughout a company’s lifecycle. With a portfolio that spans companies across Australia, Europe, Israel, and the UK, Macquarie Capital has established itself as a long-term partner for entrepreneurs driving innovation. Their hands-on approach provides founders access to an extensive network of experts, entrepreneurs, and industry partners, enabling rapid growth. Some of their current portfolio companies include BioCatch (AI-driven biometrics), D-ID (AI avatars), and Shield (digital communications governance). Macquarie Capital also integrates environmental, social, and governance (ESG) considerations into its investments, aiming to make a positive real-world impact. Beyond venture capital, Macquarie is active in areas like infrastructure, energy, and real estate, leveraging its global expertise to fuel sustainable growth in its investments.

Magenta Venture Partners is a venture capital firm founded in 2018, based in Herzliya, Israel, focused exclusively on Israeli and Israeli-related early-stage technology startups. The firm was co-founded by Ori Israely, a veteran of Giza Fund and Motorola Solutions Ventures, and Ran Levitzky, formerly of Viola Ventures, together with Japanese partners backed by Mitsui and Co. Ltd. Magenta has raised approximately $300 million to date, including a $100 million fund targeting early-stage Israeli startups. Masaji Matsuoka, former General Manager of Mitsui's global VC and healthcare operations, has served as Managing General Partner since September 2022. Magenta leads rounds and invests across automotive and mobility, enterprise software, IoT, industry 4.0, AI, fintech, and digitalization sectors. The firm has made 17 investments, initially concentrated in auto-tech and subsequently expanding into cybersecurity, AI, and software. Named portfolio companies include Onebeat, a supply chain optimization platform that raised a Series C in May 2025; Monogoto, a telecom infrastructure company; Sensos, an IoT platform; and Valens and Autotalks, both semiconductor and vehicle communication companies from the firm's original auto-tech focus. Findings, a cybersecurity company, was acquired in August 2025 — the most recent portfolio exit. Magenta's defining competitive advantage is its Israel-Japan bridge. The firm's Mitsui backing opens doors across multiple industries in Japan and provides portfolio companies with commercial access to one of the world's largest corporate ecosystems. This is particularly valuable for Israeli deep tech companies seeking to scale into Asia, where Mitsui's operational relationships across manufacturing, energy, infrastructure, and financial services create credible partnership and distribution pathways.

Makers Fund is a global venture capital firm dedicated to supporting innovative founders in the gaming and interactive entertainment sectors. Focused on early-stage investments, Makers Fund aids entrepreneurs in establishing their businesses and navigating early challenges. Notable investments include VRChat, TinyBuild, and Parsec, which was acquired by Unity. Their strategy centers on content creation, platforms, and technologies within gaming, with a global reach spanning the Americas, Asia, and EMEA. The team, including key members like Alli Ottarsson and Andrea Yang, brings extensive experience and expertise in investment and gaming. The portfolio is diverse, featuring mobile and PC games, Web3, and AI-based platforms. Recent investments include Noodle Cat Games and HypeLab, highlighting their active role in the evolving entertainment landscape. Startups seeking to connect with Makers Fund should present clear, innovative visions aligned with the fund’s focus areas. The firm values unique value propositions and scalable business models capable of thriving in the competitive gaming market. Makers Fund continues to empower the gaming ecosystem by backing the next generation of creators and innovators, ensuring a dynamic future for interactive entertainment.

Mangrove Capital Partners is a dynamic venture capital firm known for its bold, patient approach and commitment to supporting innovative entrepreneurs globally. The firm, headquartered in Luxembourg, has a strong presence in Europe with offices in Berlin, Paris, Barcelona, and London, as well as in Tel Aviv, Israel. Mangrove has a proven track record of backing successful companies, having been early investors in five unicorns: Skype, Wix, WalkMe, K Health, and TBOL. Mangrove's investment strategy focuses on early-stage tech startups, often partnering with entrepreneurs even before their product launch. They are particularly interested in transformational ideas across various sectors, including fintech, e-commerce, and health tech. Some of their rising stars include Red Points, Adverity, and Flo Health. The firm is known for its hands-on support, offering not just capital but also strategic guidance and operational assistance. Mangrove's team, comprising experienced entrepreneurs and operators, works closely with startups to navigate the challenges of scaling and growth. This approach is reinforced by their reputation for being more than just investors—they are seen as anchor partners deeply involved in their portfolio companies' success.

Maniv Mobility, founded in 2015 by Michael Granoff, is a prominent venture capital firm headquartered in Tel Aviv and New York. The firm specializes in early-stage investments focusing on the automotive, transportation, energy, and logistics sectors. Maniv Mobility has a strong global presence with investments across five continents, emphasizing innovative mobility solutions and sustainability. Notable investments in Maniv Mobility's portfolio include Turo, a peer-to-peer car rental platform; Nauto, an AI-enabled driver monitoring system; and Hailo, which develops neural processors for edge AI applications. These companies are among the three unicorns in their portfolio. Maniv Mobility has also seen several successful exits, including Arbe Robotics, Otonomo, and Voyage81. The firm's investment strategy involves pre-seed, seed, and Series A/B funding, with check sizes ranging from $1 million to $5 million. Maniv Mobility collaborates with corporate partners from the automotive and transportation industries, leveraging their expertise and networks to support startups in scaling their operations. Key team members include Michael Granoff, the founder and managing partner, and Nate Jaret, a general partner, both of whom bring extensive experience in venture capital and mobility sectors. Maniv Mobility is committed to advancing cleaner, safer, and more efficient transportation technologies, making it a pivotal player in the future of global mobility.

Manta Ray Ventures is an early-stage venture capital firm based in London, founded by Sebastian Kulczyk. The firm focuses on backing mission-driven founders who aim to address significant global challenges using advanced technologies. Manta Ray Ventures provides flexible and patient capital, leveraging their resources and networks to support their portfolio companies. Their diverse portfolio includes notable investments such as Volocopter, a manufacturer of electric copters for urban mobility; Astranis, a developer of satellite-based communication services; and Bluu Biosciences, focused on food and agriculture technology. They also have investments in companies like Epic Games, the creator of the popular game Fortnite, and Juvena Therapeutics, which is involved in drug discovery and clinical trials. Manta Ray Ventures has achieved significant exits, including the acquisition of Frontier Car Group by OLX Group and the merger of Forge Platform. The firm has also seen one of its portfolio companies, Bridge, go public on the Tokyo Stock Exchange. Led by a team of experienced professionals, including Managing Partner Lawrence Barclay and Partner Leah von Siemens, Manta Ray Ventures is dedicated to fostering innovation and supporting the growth of transformative technologies across various industries.

Mastercard's Start Path program is a global initiative designed to support innovative fintech startups and help them scale their solutions. Since its inception in 2014, Start Path has supported over 300 startups, many of which have reached significant milestones like public market entry and unicorn status. The program offers a six-month engagement period where selected startups receive dedicated support, mentorship, access to Mastercard's technology, expertise, and customer network. This enables them to innovate and scale rapidly. Start Path focuses on a broad range of fintech areas, including digital payments, financial inclusion, and small business solutions. Notable recent participants include companies like Carry1st, which leverages mobile technology to bridge the digital divide in Africa; FISPAN, which integrates business banking services into ERP systems; and Lendio, which provides small business financing solutions. The program also has a dedicated track for early-stage startups led by underrepresented founders, aiming to close the racial wealth gap and foster diversity in fintech. For startups looking to join, Mastercard offers various pathways through Start Path, including opportunities for late-stage fintech innovators and the In Solidarity track for early-stage startups. The initiative is part of Mastercard’s broader commitment to driving financial inclusion and leveraging technology to create a more inclusive digital economy.

Matrix Partners is a powerhouse in early-stage venture capital, boasting over four decades of experience and $4 billion in assets under management. Their portfolio spans transformative startups like Canva, Afterpay, Oculus, and Hubspot, among 65+ IPOs and 110+ acquisitions. With offices in San Francisco and Boston, Matrix invests globally, focusing on the U.S., India, and China. Their sweet spot is in sectors like AI, fintech, digital health, and B2B SaaS. Matrix is known for its commitment to backing founders from seed through Series A, providing checks ranging from $100K to $1M. They emphasize patience, nurturing relationships with company builders and former founders, helping them scale effectively. While they often lead rounds, Matrix also co-invests, partnering with top VCs like Y Combinator and Andreessen Horowitz. Key team members include Pranay Desai and Paul Sherer in San Francisco, and they maintain a reputation for being hands-on, leveraging deep expertise across diverse tech-driven industries. Entrepreneurs seeking funding should approach Matrix with a clear vision for scalable innovation, as the firm is laser-focused on high-impact, technology-driven ventures.

Maverick Ventures (Israel) is a Tel Aviv-based venture capital firm founded in 2013 by Yaron Carni, who previously founded the Tel Aviv Angel Group and sold the first Israeli company acquired by Google. Managing Partner Michel Abadi leads a team of 11 including three partners. The firm operates as a multi-stage platform across six funds, including Maverick Ventures Israel III, collaborating across private and public strategies to support companies from inception through IPO. A notable structural feature: 30 percent of the firm's capital is committed by Maverick partners and employees, representing the largest single LP position in the fund. Maverick invests $1 million to $3 million at Seed through Series B stages and leads rounds. The firm is sector-agnostic except for explicit exclusions covering crypto and blockchain, medical devices, chips and semiconductors, and ad tech. Since early 2023 the investment focus has centered on AI-adjacent and infrastructure-supporting companies. Across 83 total investments, the portfolio has produced 2 unicorns — Taboola and Redis — along with 2 IPOs and 16 acquisitions across 21 exits. Recent investments include Hirundo ($8 million seed for AI optimization and machine unlearning, led by Maverick, June 2025), Commure (healthcare enterprise systems, June 2025), and Wild Moose (Seed, October 2025). Other notable portfolio companies include Vendi AI, Artemis Health, and Aptible (exit November 2025). The firm's name derives from the Hebrew word meaning 'to shine,' reflecting an investment culture oriented toward conviction and differentiation. Maverick's willingness to lead from seed through late stage, combined with the large GP and team co-investment, aligns the partnership's financial interests tightly with those of portfolio founders.

Maxfield Capital is a venture capital firm specializing in early-stage investments, focusing on IT and internet sectors. Established in 2013 by Alexander Turkot, the firm has a global presence with offices in New York, Tel Aviv, and Moscow. Maxfield Capital aims to bridge the gap between high-quality engineering and commercial execution, helping startups scale globally. The firm's investment focus includes sectors such as e-health, digital lending, data protection, mobility, e-education, marketplaces, and cloud computing. Maxfield Capital typically invests in companies that are beyond the seed stage, preferring those with more advanced development​. Alexander Turkot, the founder and managing partner, brings extensive experience from his background in IT, engineering, and project management, including significant roles at IBM and the Skolkovo project. Other key partners include Oleg Koujikov and Alexander Lazarev, who manage operations across various regions.

Medison Ventures is the corporate venture capital arm of Medison Pharma, one of the world's largest commercial partners for innovative pharmaceutical companies with operations in Israel, Canada, and Eastern Europe. Founded in 2016 by Meir Jakobsohn and headquartered in Petah Tikva, Israel, the firm focuses on in-licensing, equity investments, and scouting for breakthrough technologies in biotechnology and digital health. Investment activity is concentrated at the Series B stage in life sciences companies. The portfolio comprises approximately 10 investments across biotech, pharma, and digital health. Notable holdings include Alpha Tau Medical, an alpha particle cancer therapy company that completed a NASDAQ IPO in March 2021, along with Keros Therapeutics, Eloxx Pharmaceuticals, Apeiron Biologics, Allogene Therapeutics, Orchard Therapeutics, and ArQule. In 2019, Medison Ventures partnered with Pontifax to launch a $150 million venture debt fund providing clinical-stage life science companies with non-dilutive capital. Portfolio companies benefit from direct access to Medison Pharma's global network of pharmaceutical partners including Biogen, Vertex, Shire, BioMarin, IPSEN, Servier, PTC Therapeutics, and Daiichi-Sankyo. The fund's primary value proposition is commercial access: portfolio companies gain introductions to established pharmaceutical distributors and commercial partners through Medison Pharma's existing relationships, potentially accelerating the path from clinical development to market. The fund is currently presumed inactive with no publicly recorded recent investments, reflecting the typical life cycle of a focused corporate VC vehicle tied to its parent's strategic priorities.

Mediterranean Towers Ventures is an AgeTech-focused corporate venture capital firm backed by Mediterranean Towers (TASE: MDTR), Israel's market-leading retirement living developer and operator. Founded in 2017 and based in Ganei Tikva, Israel, it is the first Israeli investment fund focused exclusively on technological innovations for older adults. The fund opened trading on the Tel Aviv Stock Exchange in a ceremony led by TASE CEO Mr. Ben-Zeev and Mediterranean Towers Chairman Yair Seroussi. Managing Director Omer Brakin, who also serves as VP of Business Development at Mediterranean Towers, leads a team of approximately 12 with backgrounds spanning venture investment, capital markets, real estate, and healthcare. The fund invests at pre-seed and seed stages in Israeli AgeTech startups tackling loneliness, improving medical outcomes, and enhancing quality of life for older adults. Check sizes range from $100,000 to $500,000. The portfolio of six companies includes Maolac (AI-powered bio-functional proteins derived from milk, invested July 2022), Travaxy (accessible travel platform), XRHealth (a VR and AR therapeutic healthcare platform that acquired RealizedCare in February 2025 and NeuroReality in November 2024), Uniper (eldercare fitness), and APA. The fund's primary competitive advantage is direct market access through Mediterranean Towers' retirement communities, providing portfolio companies with four decades of institutional relationships with older adults and real-world testing environments that pure financial investors cannot replicate. Portfolio companies gain structured access to genuine end users, clinical feedback loops, and commercial pathways within the Israeli eldercare ecosystem.

MEDX Ventures Group is a Hingham, Massachusetts-based investment and management company founded in 2010 by Harel, who serves as CEO and Company Group Chairman, with offices in the US, Europe, and Israel. The firm focuses on Israeli medical technology and robotic companies, applying a proprietary 'X Model' that provides active management through dedicated Development, Regulatory, Commercial, and Finance teams embedded alongside portfolio companies throughout their lifecycle. In 2015, MEDX raised $30 million for Israeli biomed startups and established MEDX Xelerator, a leading medical-device-focused incubator operating under the auspices of the Israel Innovation Authority. MEDX Xelerator is located in Or Yehuda and Sakhnin, Israel, and partners with Boston Scientific, Sheba Medical Center, Intellectual Ventures, Consensus Business Group, West Pharmaceuticals, Wolfson Hospital, Weill Cornell Medicine Enterprise Innovation, and Ichilov Hospital. Innovation areas include vascular, interventional cardiology, urology, interventional oncology, medical robotics, and digital health solutions. MEDX leads rounds and invests at pre-seed through Series A stages. Across approximately 8 investments, the portfolio includes Microbot Medical (IPO), XACT Robotics (Harel serves as Chairman), Append Medical ($7.4 million Series A), and VeinWay (most recent seed investment, March 2023). The related Edge Medical Ventures launched a $70 million medtech fund to complement MEDX's earlier-stage activity. The MEDX model differs from conventional medtech VCs in that its team actively manages regulatory strategy, commercial development, and financing alongside founders rather than providing capital and periodic board oversight. This hands-on operational approach is designed to reduce time-to-market and de-risk regulatory submissions for hardware-intensive medical devices and robotic surgical systems.

Menara Ventures is a publicly traded venture capital firm listed on the Tel Aviv Stock Exchange (TASE: MNRA), investing in early-stage digital transformation startups. Founded on February 17, 2021 by Eran Savir, Yefi Gureni, and Zvika Barinboim, the firm is headquartered in Tel Aviv, Israel, with a team of four partners combining technology entrepreneurship and investment management experience spanning more than 20 years. Eran Savir previously managed Intango Ventures and founded two startups that were both acquired. Yefi Gureni is co-founder and chairman of Intango, an international digital marketing technology company, and owner of Intango Ventures. Menara leads rounds and invests at Seed and Series A stages with check sizes typically between $500,000 and $3 million, targeting experienced founders building global brands around unique technologies in Israel-related digital transformation. The firm invests across the venture value chain from seed through exits and IPOs, leveraging its network of founders and industry executives for early deal access. The portfolio comprises five companies: SensePass (a digital payment network enabling brick-and-mortar merchants to accept e-wallets, crypto, and loyalty points), LeO, Matics, Pairzon, and Revuze. Investments are concentrated in enterprise applications and high-tech sectors. The firm averages approximately one new investment per year and has not publicly recorded investments in 2024 or 2025. As a publicly listed VC vehicle on TASE, Menara Ventures operates with a level of transparency uncommon for early-stage funds, providing Israeli retail investors with structured exposure to digital transformation startups led by founders with demonstrated exit track records.

Mendoza Ventures, co-founded by Adrian and Senofer Mendoza, is a Boston and San Francisco-based venture capital firm specializing in early-stage investments in AI, cybersecurity, and fintech. The firm is known for its strong focus on diversity, with 90% of its portfolio companies led by immigrants, people of color, or women. Since its founding, Mendoza Ventures has raised three funds and supported over 15 startups, with several successful exits, including Alyce, acquired by Sendoso, and Finch, acquired by Finder. Their hands-on approach means they limit their portfolio to 12-15 companies, allowing them to dedicate significant time and resources to each startup, meeting weekly with founders to provide strategic guidance and operational support. Mendoza Ventures’ focus on diversity and inclusion, combined with their deep domain expertise in AI, fintech, and cybersecurity, positions them as leaders in driving innovation in these sectors. The firm has secured significant investments from major financial institutions, including Bank of America and Truist, underscoring their commitment to closing the wealth gap and supporting underrepresented founders.

Mento VC is an institutional venture capital firm founded in 2023 and based in Wilmington, Delaware, investing in startups driving the future of work, automation, AI, and productivity. Founder and General Partner Alex Zhuravlev brings 14 years in technology and 8 years in venture capital, most recently as Portfolio Director at AltaIR Capital ($600 million AUM) where he oversaw more than 350 startups and supported 10 unicorns and 2 decacorns. Ekaterina serves as COO managing investor relations, capital calls, and founder support. Mento invests at pre-seed and seed stages with check sizes typically between $100,000 and $1 million, targeting teams from the United States, United Kingdom, and Israel building productivity tools, future-of-work platforms, B2B SaaS enterprise software, fintech, and HRTech. Across approximately 25 investments, the firm has built a portfolio of AI-driven companies that includes Artisan AI (digital workers for sales automation), Eragon AI ($8 million seed, December 2025 — AI operating system for enterprise), Leo AI ($5 million seed, September 2025 — AI copilot for mechanical engineering), Final Round AI (interview preparation), Clerk Chat (business text messaging), Openlayer ($14.5 million Series A, May 2025 — automated testing), sync.so, Tella, Phia, Alma, AvatarOS, Mirai Tech, and Rork (software development, April 2026). Mento's investment pace is notably active for a fund launched in 2023, reflecting Zhuravlev's thesis that the current AI cycle is producing durable productivity companies at an accelerated rate. The firm's focus on the intersection of AI, automation, and enterprise workflows across US, Israeli, and European founding teams positions it to source deals across the most active clusters of AI talent globally.

Meron Capital, founded in 2017 and based in Tel Aviv, is an early-stage venture capital firm focused on investing in deep-technology software startups. The firm, led by managing partners Liron Azrielant and Daniel Roditi, has raised two funds, Meron I and Meron II, each with $50 million. Meron Capital primarily invests in sectors such as enterprise software, cybersecurity, digital health, fintech, and DevOps, targeting pre-seed and seed-stage companies. Notable investments by Meron Capital include Loom Systems, acquired by ServiceNow; Reshuffle, acquired by Twitter; Clear Genetics, acquired by Invitae; and Axonize, acquired by Planon. The firm’s current portfolio also includes promising startups like LendAI, Sorbet, Firmbase, and Laminar​. Meron Capital prides itself on a founder-first approach, providing not just capital but also strategic guidance and leveraging their extensive network to help startups scale. They emphasize backing resilient and technically proficient founders who are capable of pushing through challenges and leveraging subtle expert feedback to refine their business models​.

Noshaq is an investment fund based in Liège, Belgium, that offers a range of financing solutions aimed at fostering the creation and growth of companies, particularly SMEs. Established in 1985 under the name Meusinvest, the organization has grown significantly and rebranded to Noshaq in 2019 to better reflect its innovative and dynamic approach to investment. Noshaq manages a portfolio of 477 companies and has supported over 1,020 companies since its inception. The fund's primary focus areas include biotechnology, industry 4.0, digital technology, quality food, real estate, energy, sustainable development, and cultural industries. They provide funding through various vehicles, including equity investments, loans, and leasing, tailored to the specific needs of each stage of a company's development. Notable initiatives under Noshaq include Noshaq Spin-Offs, which supports the creation of spin-offs in collaboration with the University of Liège, and LeanSquare, which focuses on innovative projects in cultural and creative industries, enterprise software, and life sciences. Additionally, Noshaq is actively involved in regional development projects, such as La Grand Poste, a creative hub in the heart of Liège.

Maschmeyer Group Ventures (MGV) is a San Francisco-based early-stage venture capital firm founded in 2017 by Marc Schroeder (Founding and Managing Partner) and Carsten Maschmeyer (Founding Partner and Chairman), one of Germany's most prominent entrepreneurs and investors. The firm positions itself as a top-quartile SaaS fund focused on exceptional American technology companies, with offices in San Francisco, Munich, Berlin, and Hannover and a team of seven including three partners. MGV's primary geographic focus spans North America, Latin America, and Israel. The firm invests up to $750,000 at the Seed and Series A stages alongside a lead investor, concentrating on SaaS, AI and machine learning, fintech, proptech, e-commerce, and data analytics. Across 63 total investments, the portfolio has generated 6 exits including Telivy (January 2025), Modern Health (2024), and Observe.AI (2022). Recent investments include Woz (business productivity software, October 2025) and Cascade Space. Other notable portfolio companies include Runa HR, Glide (no-code application builder), and Tomorrow Ideas. MGV's defining value-add is hands-on go-to-market support: the team actively helps founders build scalable sales organizations, open enterprise customer channels, and develop repeatable revenue models. The firm's founder-first evaluation approach prioritizes drive, humility, and leadership capacity over strict traction or revenue thresholds, reflecting the belief that the best SaaS outcomes are built by exceptional people as much as exceptional products. Maschmeyer's European network and Schroeder's operational background give portfolio companies a transatlantic perspective during the critical early scaling phase.

Middleland Capital, a venture capital firm founded in 2010 and based in Washington, D.C., focuses on innovative foodtech and agtech companies. With over $100 million invested and a portfolio of 25 direct investments, the firm supports high-growth companies that are looking to scale their de-risked technology and proven business models​. The firm's notable investments include AeroFarms, the largest indoor vertical farming company in the US; Soli Organic, a leading grower and marketer of fresh organic culinary herbs; and MycoTechnology, an ingredient company that utilizes proprietary processes to remove flavor defects in food products without chemicals or GMOs​​. Other significant investments include EarthOptics, which provides real-time soil data maps, and Farmwise, which develops systems to streamline farming operations and increase food production efficiency​. Middleland Capital has a strong track record of successful exits, such as Seventh Generation, which was acquired by Unilever, and Benson Hill, which went public on the NYSE. The firm continues to catalyze global change in food and health through its targeted investments in innovative technologies and sustainable solutions.

Millennium Global Opportunities is a Luxembourg-based mixed-asset fund managed by Millennium FT. It offers investment opportunities to both mutual and institutional investors, with tailored fee structures for each group. The fund adopts an opportunistic investment strategy, actively managing a diverse portfolio that includes equities, currencies, interest rates, and futures. It also prioritizes risk management to capitalize on global trends while minimizing potential downsides. Since 2018, Millennium Global Opportunities has integrated environmental, social, and governance (ESG) factors into its investment decision-making process, reflecting a commitment to sustainability. The fund’s focus on sustainability aligns with the broader global shift towards responsible investing, as it aims to generate positive financial returns while considering the long-term environmental and social impacts of its investments. The fund currently manages over €25 million in assets and targets growth through investments in large-cap stocks, as well as sustainable assets. Key holdings in the fund's portfolio include Xetra-Gold, U.S. Treasury Notes, and other high-quality assets that offer both security and potential for appreciation. Millennium Global Opportunities has also earned recognition in the investment community, winning multiple Lipper Fund Awards for excellence in the Absolute Return category. Millennium FT's active management approach, combined with a strong focus on sustainability and risk mitigation, makes it a versatile investment vehicle for those looking to balance growth with responsibility. The fund is particularly well-suited for investors who are seeking to diversify their portfolios with a blend of traditional and sustainable assets.

Mindset Ventures is an early-stage venture capital firm with a focus on B2B tech startups in sectors like fintech, cybersecurity, agriculture, healthcare, and enterprise software. The firm primarily invests in the U.S. and Israel, but its roots in Brazil make it a powerful gateway for companies expanding into Latin America. Mindset is known for its strategic support, offering portfolio companies access to key business development opportunities, especially in the Brazilian market. Notable investments include Turing, PayJoy, and Pecan, where the fund has been pivotal in helping these companies with international growth. Mindset's investment strategy combines agility with thorough due diligence, often co-investing alongside top-tier VCs. They generally target early-stage startups with tickets ranging from $1 million to $5 million and prefer companies with coachable founders open to strategic guidance. Co-founded by Daniel Ibri, who leads from São Paulo, the team is well-versed in international expansion, helping companies scale beyond their initial markets. For startups seeking funding, Mindset values transparency and expects a well-researched approach that highlights how founders plan to scale globally.

Mistletoe, a venture capital firm based in Kanazawa, Japan, was founded by Taizo Son and Atsushi Taira in 2013. The fund focuses on early-stage investments in tech-driven startups with a strong emphasis on sustainability and social impact. Notable investments include Zipline, Playco, and Sea, reflecting their commitment to innovative and impactful ventures. Mistletoe's industry focus spans across biotechnology, clean energy, health tech, and entertainment, showing a diverse portfolio aimed at transformative technologies. Geographically, their investments are global, covering North America, Asia, and Europe, with recent activities in countries like Japan, the U.S., and Finland. Their strategy revolves around partnering with visionary founders who tackle global challenges. Mistletoe typically invests in seed to series A stages, often leading rounds with an average check size of around $2 million. They have a collaborative approach, frequently co-investing with firms like Sequoia Capital and Plug and Play Tech Center. Active in fostering an ecosystem of like-minded investors and entrepreneurs, Mistletoe values innovation and societal contributions highly. The team, including key members like Michael Kim and Satoshi Fujimura, is primarily based in Japan with a significant presence in Singapore. Startups looking to engage with Mistletoe should emphasize their mission-driven goals and innovative solutions. Approaching them through warm introductions and clear, impactful pitches increases the chances of successful engagement​.